The discrepancy of opinions on the effectiveness of such approach may be explained by utilization of different assessment protocols, including variations in cutoff levels, percentage of positive cells versus staining intensity, PD-L1 expression on tumor cells versus microenvironment. The gene discussed is CD274; the disease is neoplasm.